Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain [version 1; peer r...
Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain [version 1; peer review: 2 approved, 1 approved with reservations]
About this item
Full title
Author / Creator
Publisher
England: Faculty of 1000 Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Faculty of 1000 Ltd
Subjects
More information
Scope and Contents
Contents
Background: There are no known medicines or vaccines to control the COVID-19 pandemic caused by SARS-CoV-2 (nCoV). Antiviral peptides are superior to conventional drugs and may also be effective against COVID-19. Hence, we investigated the SARS-CoV-2 Spike receptor-binding domain (nCoV-RBD) that interacts with hACE2 for viral attachment and entry.<...
Alternative Titles
Full title
Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain [version 1; peer review: 2 approved, 1 approved with reservations]
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c3d34504b37e41c69e53ba26929c4f07
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c3d34504b37e41c69e53ba26929c4f07
Other Identifiers
ISSN
2046-1402
E-ISSN
2046-1402
DOI
10.12688/f1000research.24074.1
